阿拉丁前三季度营收4.44亿元同比增17.59%，归母净利润5776.03万元同比降20.41%，毛利率下降0.06个百分点

Core Insights - Aladdin's revenue for the first three quarters of 2025 reached 444 million yuan, representing a year-on-year increase of 17.59% [1] - The company's net profit attributable to shareholders was 57.76 million yuan, a year-on-year decrease of 20.41% [1] - The basic earnings per share stood at 0.17 yuan [1] Financial Performance - The gross profit margin for the first three quarters of 2025 was 63.02%, a slight decrease of 0.06 percentage points year-on-year [2] - The net profit margin was 17.38%, down 4.96 percentage points compared to the same period last year [2] - In Q3 2025, the gross profit margin improved to 66.27%, an increase of 4.44 percentage points year-on-year and 6.02 percentage points quarter-on-quarter [2] - The net profit margin for Q3 2025 was 22.81%, up 0.36 percentage points year-on-year and increased by 16.56 percentage points from the previous quarter [2] Expense Analysis - Total operating expenses for the period were 183 million yuan, an increase of 52.47 million yuan year-on-year [2] - The expense ratio was 41.32%, up 6.63 percentage points from the same period last year [2] - Sales expenses increased by 38.45%, management expenses rose by 38.37%, R&D expenses grew by 10.84%, and financial expenses surged by 761.11% [2] Shareholder Information - As of the end of Q3 2025, the total number of shareholders was 11,600, a decrease of 894 from the end of the previous half-year, representing a decline of 7.17% [2] - The average market value per shareholder increased from 339,200 yuan at the end of the previous half-year to 374,400 yuan, a growth of 10.35% [2] Company Overview - Shanghai Aladdin Biochemical Technology Co., Ltd. was established on March 16, 2009, and went public on October 26, 2020 [3] - The company's main business involves the research, development, production, and sales of reagents, with research reagents accounting for 96.96% of revenue [3] - Aladdin operates in the basic chemical industry, specifically in the chemical products sector, and is associated with concepts such as synthetic biology, e-commerce, scientific instruments, and specialized innovation [3]